Autoimmune diseases, immune modulation, inflammation, and self-tolerance
203 articles
Researchers identify the molecular mechanism controlling STING protein trafficking, revealing new targets for cancer immunotherapy.
Researchers identify exact antibody binding sites on brain receptors, opening door to targeted treatments and earlier diagnosis.
Scientists identify CD20+CD3+ T cells that worsen rheumatoid arthritis by converting protective immune cells into inflammatory ones.
New research reveals how IL-1β and TGF-β cytokines work together to fuel joint inflammation and damage in rheumatoid arthritis patients.
Daratumumab monotherapy showed promising results in treating refractory lupus nephritis by reducing inflammation and fibrosis.
Cutting-edge genomic and immune profiling techniques uncover promising pathways for treating this chronic autoimmune condition.
New research reveals how circulating factors in autoimmune disease blood can directly cause muscle weakness and cellular dysfunction.
Major meta-analysis reveals people with type 1 diabetes face nearly 3x higher depression risk, while celiac disease increases risk by 66%.
Scientists discover unique immune peptide patterns in Behçet's disease patients that trigger harmful inflammation responses.
New research reveals how metabolic molecules function as signaling agents that control immune responses within tumors.
Dying cancer cells release GPX4 protein that prevents immune system activation, revealing new immunotherapy targets.
New research reveals how RNA-binding proteins orchestrate immune responses, offering insights into preventing chronic inflammation.
